Choe S Y, Neudeck B L, Welage L S, Amidon G E, Barnett J L, Amidon G L
Pharmaceutical Research Institute, Bristol-Myers Squibb, Princeton, NJ 08543-4000, USA.
Eur J Pharm Sci. 2001 Dec;14(4):347-53. doi: 10.1016/s0928-0987(01)00196-8.
To further validate the Pellet Gastric Emptying Test (PGET) as a marker of gastric emptying, a randomized, four-way crossover study was conducted with 12 healthy subjects. The study consisted of oral co-administration of enteric coated caffeine (CAFF) and acetaminophen (APAP) pellets in four treatment phases: Same Size (100 kcal), Fasted, Small Liquid Meal (100 kcal), and Standard Meal (847 kcal). The time of first appearance of measurable drug marker in plasma, t(initial), was taken as the emptying time for the markers. Co-administration of same size enteric coated pellets of CAFF and APAP (0.7 mm in diameter) revealed no statistically significant differences in t(initial) values indicating that emptying was dependent only on size and not on chemical make-up of the pellets. Co-administration of different size pellets indicated that the smaller 0.7-mm diameter (CAFF) pellets were emptied and absorbed significantly earlier than the larger 3.6-mm diameter (APAP) pellets with both the Small Liquid Meal (by 35 min) and the Standard Meal (by 33 min) (P<0.05). The differences in emptying of the pellets were not significant in the Fasted Phase. The results suggest that the pellet gastric emptying test could prove useful in monitoring changes in transit times in the fasted and fed states and their impact on drug absorption.
为进一步验证颗粒胃排空试验(PGET)作为胃排空标志物的有效性,对12名健康受试者进行了一项随机、四交叉研究。该研究包括在四个治疗阶段口服肠溶咖啡因(CAFF)和对乙酰氨基酚(APAP)颗粒:等大(100千卡)、空腹、小液体餐(100千卡)和标准餐(847千卡)。将血浆中可测量药物标志物首次出现的时间t(初始)作为标志物的排空时间。同时给予等大的肠溶CAFF和APAP颗粒(直径0.7毫米),t(初始)值无统计学显著差异,表明排空仅取决于颗粒大小,而非颗粒的化学组成。同时给予不同大小的颗粒表明,直径较小的0.7毫米(CAFF)颗粒在小液体餐(提前35分钟)和标准餐(提前33分钟)时排空和吸收均明显早于直径较大的3.6毫米(APAP)颗粒(P<0.05)。在空腹阶段,颗粒排空的差异不显著。结果表明,颗粒胃排空试验可能有助于监测空腹和进食状态下转运时间的变化及其对药物吸收的影响。